Reading this on a mobile device? Try our optimized mobile version here:

March 27, 2013
Sign upForwardArchiveAdvertise
News for and about dermatologic surgeons

  Healthy, Beautiful Skin 
  • Damage from temporary tattoos can be permanent, FDA warns
    Temporary black henna tattoos might be made with a dye containing p-phenylenediamine can lead to dangerous reactions, including blisters, weeping lesions, loss of color, photosensitivity and permanent scars, the FDA is warning. The dye is banned from cosmetics intended for the skin. HealthDay News (3/26) LinkedInFacebookTwitterEmail this Story
Revolutionary New VEOS Dermatoscopes from Canfield

The innovative new VEOS dermatoscopes from Canfield combine ease of use with the power of mobile imaging. VEOS HD1 and HD2 deliver crisp, bright visualization in a compact, ergonomic design. VEOS DS3 provides a complete digital dermoscopy solution with a swing away lens for overview photos, touch screen controls and dual mode lighting. Read more.
  Tools of the Trade 
  • Device uses rocket science to detect melanoma
    More dermatologists are using the MelaFind device to analyze potentially cancerous skin lesions in an effort to detect and treat cancer early. The device employs the same technology used to detect missiles, says dermatologist Susan Weinkle, ASDS' immediate past president. It compares lesion pigmentation and depth to a database of 10,000 moles to determine the likelihood that a lesion is melanoma, Weinkle says. WFTS-TV (Tampa, Fla.) (3/22) LinkedInFacebookTwitterEmail this Story
  • J&J threatens to put a wrinkle in Botox's dominance
    Johnson & Johnson expects to receive FDA approval next year for a wrinkle-reducing injection similar to Allergan's Botox. Allergan already faces competition from Valeant's Dysport and Merz's Xeomin, but it has an 85% market share. Reuters (3/22) LinkedInFacebookTwitterEmail this Story
  • Hamburg suggests fees for oversight of drug compounders
    FDA Commissioner Dr. Margaret Hamburg said in a post on her agency's blog Friday that compounding pharmacies should pay fees for the FDA oversight needed to prevent a recent meningitis outbreak from happening again. Hamburg is hoping that the Senate committee in control of the issue "will yield strong legislation for patients across the nation" as serious problems persist in compounding pharmacies. Congress could use registration or other kinds of fees to finance additional oversight, Hamburg said. Reuters (3/22), (3/25) LinkedInFacebookTwitterEmail this Story
  Perfecting Your Practice 
  • HHS raises concerns about doctor-owned device distributors
    The HHS inspector general's office is raising concerns about doctor-owned medical device distributorships in which physicians can benefit financially from the use of devices in procedures they order. The alert follows previous advisories on business models, and among the practices that are cautioned against are tying investment amounts to the volume of devices used. (3/27) LinkedInFacebookTwitterEmail this Story
  • New HIPAA rules cover business associates, patient control
    HIPAA privacy and security rules now cover business associates of HIPAA-covered entities, including insurers, claims clearinghouses, software contractors and vendors, office-based health care providers and analytics firms. Covered entities and their business associates that did not have compliant agreements in place before Jan. 25 must have contracts in place by Sept. 23; others are granted a one-year grace period. New rules also allow patients who pay out-of-pocket for treatment to forbid providers from sharing records of that treatment with insurers. Modern Healthcare (subscription required) (3/25) LinkedInFacebookTwitterEmail this Story
  ASDS News 
  • New laser techniques offer safer and more effective procedures
    Quickly evolving advances in devices and techniques along with expanding publicity have increased patient demand and expectations for laser and skin therapy. Enhance your skills while evaluating emerging technologies during the ASDS Mastery of Lasers for Optimal Patient Outcomes offered April 20 and 21 in New York. The combination of a practical hands-on session and in-depth discussions -- all in a small class size -- provides an invaluable opportunity to learn best practices from the experts and compare devices. Review the agenda and register now online or by calling (847) 956-0900. LinkedInFacebookTwitterEmail this Story

  • Increase patient confidence -- display your ASDS membership!
    As patients become more educated, they increasingly look for credentials when selecting their dermatologist. Distinguish yourself from your peers by visually displaying your ASDS membership with ASDS membership plaques. Available in four different finishes to match every office décor, present them in exam rooms to signify your dedication to the highest standards of patient care and excellence in dermatologic surgery. To order, visit or call (847) 956-0900. LinkedInFacebookTwitterEmail this Story
Learn more about ASDS ->Find a dermatologic surgeon | Why choose a dermatologic surgeon? | Join ASDS

To know oneself, one should assert oneself."
--Albert Camus,
French author, journalist and philosopher

LinkedInFacebookTwitterEmail this Story


This service is provided as a timely update to ASDS members and other health professionals about dermatologic surgery topics in the media. Links to articles are provided for the convenience of dermatologic surgeons who may find them of use in discussions with patients and colleagues.
External Resources are not a part of the website. The ASDS is not responsible for the content of sites that are external to the ASDS. Linking to a website does not constitute an endorsement by the ASDS of the sponsors of the site or the information presented on the site.

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Sales Associate:  Aaron Kern (202) 407-7866
A powerful website for SmartBrief readers including:
 Recent ASDS Skin Source SmartBrief Issues:   Lead Editor:  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information